Recently, Boccardi et al[32] showed that there was an interaction between the inflammatory molecule IL-17 and microRNA in male patients with Alzheimer disease, and revealed that miR-122 might be a good candidate regulator. This evidence concerns the gene IL17A and early-onset autosomal dominant Alzheimer disease.